Home  >  Products  >  KHDRBS1 (KH domain containing, RNA binding, signal transduction associated 1) Blocking Peptide (100ug)
KHDRBS1 (KH domain containing, RNA binding, signal transduction associated 1) Blocking Peptide (100ug)

KHDRBS1 (KH domain containing, RNA binding, signal transduction associated 1) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KHDRBS1 antibody (Catalogue #: ARP40665_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40665
Size: 100 ug
Weight: 48kDa
Gene: 10657
Format: Lyophilized powder
Target: KHDRBS1 recruited and tyrosine phosphorylated by several receptor systems, for example the T-cell, leptin and insulin receptors. Once phosphorylated, KHDRBS1 functions as an adapter protein in signal transduction cascades by binding to SH2 and SH3 domain-containing proteins. KHDRBS1 play a role in G2-M progression in the cell cycle. It represses CBP-dependent transcriptional activation apparently by competing with other nuclear factors for binding to CBP. KHDRBS1 also acts as a putative regulator of mRNA stability and/or translation rates and mediates mRNA nuclear export.
Alternative names: FLJ34027; Sam68; p62
See Full Product Listings >